Eli Lilly (LLY 0.66%) and Novo Nordisk (NVO -0.16%) are competing in the market for weight loss and diabetes treatments.
*Stock prices used were the afternoon prices of Aug. 9, 2025. The video was published on Aug. 11, 2025.
Free Article
You're reading a free article with opinions that may differ from The Motley Fool's Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More
Best Stock to Buy: Eli Lilly Stock vs. Novo Nordisk Stock
By Parkev Tatevosian, CFA
–
Aug 12, 2025 at 10:40AM
NYSE: LLY
Eli Lilly
Market Cap
$605B
Today's Change
(0.66%) $4.22
Current Price
$639.44
Price as of August 12, 2025, 3:58 p.m. ET
Investors have a tough choice between these two excellent companies.
About the Author
A Fool since 2019, and a graduate of Cal State LA with a B.S. in Finance and M.A. in Economics. Parkev is an adjunct professor of Finance and enjoys reading about financial and economic history. You'll often find him writing about stocks in the consumer goods and technology sectors.
Parkev Tatevosian, CFA has no position in any of the stocks mentioned. The Motley Fool recommends Novo Nordisk. The Motley Fool has a disclosure policy. Parkev Tatevosian is an affiliate of The Motley Fool and may be compensated for promoting its services. If you choose to subscribe through his link, he will earn some extra money that supports his channel. His opinions remain his own and are unaffected by The Motley Fool.
Stocks Mentioned
Eli Lilly
LLY
$639.44
(0.66%)
$4.22
Novo Nordisk
NVO
$49.79
(-0.16%)
$0.08
*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.
Related Articles
1 Reason to Buy Eli Lilly (LLY) Stock
If You'd Invested $1,000 in Eli Lilly (LLY) Stock 5 Years Ago, Here's How Much You'd Have Today
Why Eli Lilly Stock Popped Today
Why Eli Lilly Stock Sank 18% This Week
Does This $856 Million Investment Make Eli Lilly Stock a Buy?
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.